Innovation
2 patent families (1 granted) — focus: Human necessities; filing pace dormant. Cited 2 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
Investor mix
3 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Topical gel for the treatment of actinic (solar) keratosis.
2 patent families (1 granted) — focus: Human necessities; filing pace dormant. Cited 2 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
3 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |